Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Receivables (2017 - 2025)

Historic Change in Receivables for AC Immune (ACIU) over the last 9 years, with Q3 2025 value amounting to $36252.2.

  • AC Immune's Change in Receivables fell 8980.24% to $36252.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 19888.44%. This contributed to the annual value of $16.9 million for FY2024, which is 20125.67% up from last year.
  • Latest data reveals that AC Immune reported Change in Receivables of $36252.2 as of Q3 2025, which was down 8980.24% from $485571.9 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Change in Receivables ranged from a high of $17.1 million in Q4 2024 and a low of -$16.7 million during Q4 2023
  • Over the past 5 years, AC Immune's median Change in Receivables value was -$64258.6 (recorded in 2021), while the average stood at -$13292.9.
  • Examining YoY changes over the last 5 years, AC Immune's Change in Receivables showed a top increase of 427444.12% in 2022 and a maximum decrease of 617636.18% in 2022.
  • Quarter analysis of 5 years shows AC Immune's Change in Receivables stood at -$95436.2 in 2021, then surged by 4274.44% to $4.0 million in 2022, then tumbled by 518.41% to -$16.7 million in 2023, then skyrocketed by 202.74% to $17.1 million in 2024, then crashed by 99.79% to $36252.2 in 2025.
  • Its Change in Receivables stands at $36252.2 for Q3 2025, versus $485571.9 for Q2 2025 and -$947637.4 for Q1 2025.